THC and Ketamine Effects in Humans: Relation to Neural Oscillations and Psychosis
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The aim of the research protocol is to evaluate cannabinoid-glutamate interactions in humans.
As part of this aim the investigators will assess the safety and tolerability of the
combination of NMDA antagonist, ketamine, and the cannabinoid, delta-9-tetrahydrocannabinol
(THC), in healthy adult subjects, and characterize the interactive effects of ketamine and
THC on various electrophysiological (EEG), cognitive, and behavioral outcomes.